跳至主要内容
临床试验/JPRN-UMIN000015389
JPRN-UMIN000015389已完成未知

Potential detectability of blood flow in hepatocellular carcinoma using contrast-enhanced ultrasonography with Sonazoid (Comparison with transvenous contrast-enhanced computed tomography or computed tomography with angiography) - Potential detectability of tumor blood flow using contrast-enhanced ultrasonography

Chiba University Graduate School of Medicine, Department of Gastroenterology and Nephrology0 个研究点目标入组 100 人开始时间: 2014年10月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Egg allergy 2. Severe lung disease 3. Severe heart disease 4. Hepatocellular carcinomas are not supplied by hepatic artery. 5. Tumors are diagnosed not to be hepatocellular carcinomas. 6. Determined to be ineligible by the physician in charge for any other reason.

研究者

发起方
Chiba University Graduate School of Medicine, Department of Gastroenterology and Nephrology

相似试验